Anti-inflammatories/bromocriptine/ceftriaxoneLack of efficacy, off-label use and drug exposure during pregnancy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1969卷 / 1期

关键词：

D O I：

10.1007/s40278-023-44502-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：36 / 36

相关论文

共 50 条

[1] Anti-inflammatories/vancomycinLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1984 (1) : 55 - 55
[2] Anti-inflammatories/Azathioprine/SteroidsLack of efficacy and off-label use
Reactions Weekly, 2023, 1988 (1) : 25 - 25
[3] Multiple drugsLack of efficacy, off-label use and drug exposure during pregnancy : case report
Reactions Weekly, 2023, 1983 (1) : 315 - 315
[4] Multiple drugsLack of efficacy, off-label use and drug exposure during pregnancy: case report
Reactions Weekly, 2021, 1883 (1) : 264 - 264
[5] Aciclovir/ceftriaxoneLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1918 (1) : 19 - 19
[6] Anti-inflammatories/unspecified glucocorticoidsAllergic drug reaction, infusion-related reaction following off-label use and lack of efficacy: 3 case report
Reactions Weekly, 2022, 1905 (1) : 50 - 50
[7] MethylprednisoloneDrug exposure during pregnancy, lack of efficacy and off-label use: case report
Reactions Weekly, 2024, 2030 (1) : 283 - 283
[8] CeftriaxoneLack of efficacy and drug exposure during pregnancy: case report
Reactions Weekly, 2025, 2051 (1) : 85 - 85
[9] Anti inflammatories/corticosteroidsLack of efficacy and norovirus gastroenteritis following off-label use: case report
Reactions Weekly, 2023, 1959 (1) : 67 - 67
[10] Anti-inflammatories/Bimekizumab/ElasomeranErythrodermic pityriasis rubra pilaris, exacerbation, lack of efficacy and off-label use
Reactions Weekly, 2024, 1989 (1) : 28 - 28

← 1 2 3 4 5 →